產品詳情
簡單介紹：
Anti-BPIL1抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-BPIL1抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-BPIL1
Cat. Number:
Anti-BPIL1抗體KL-8423R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Members of the bactericidal/permeability-increasing protein family have antimicrobial properties and bind lipophilic substances, Anti-BPIL1抗體therefore targeting gram-negative bacteria. The bactericidal permeability increasing protein (BPI) is an antibacterial and endotoxin-neutralizing molecule that is abundant in the granules of polymorphonuclear leukocytes (neutrophil granules). Sharing structural and sequence homologies with BPI, BPIL1 (bactericidal/permeability-increasing protein-like 1) is a 458 amino acid secreted protein that contains the family’s common conserved feature of two cysteine residues that are critical for protein function. While BPIL1 is primarily expressed at low levels in tonsil tissue, it has been found to be upregulated in hypertrophic tonsils, suggesting that it may play Anti-BPIL1抗體a role in the pathogenesis of inflamed disease tissue.
Also known as:
Bactericidal permeability increasing protein like 1; C20orf184; dJ726C3.2; Long palate lung and nasal epithelium carcinoma associated 2; Long palate lung and nasal epithelium carcinoma associated protein 2;Anti-BPIL1抗體 LPLUNC2; RYSR.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Pig, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human BPIL1.
●
Predicted Molecular Anti-BPIL1抗體Weight: 47kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications.
Optimal working Anti-BPIL1抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-BPIL1抗體dilutions must be determined by the end user.
kl048Hu01 HtrA絲氨酸肽酶4(HTRA4)多克隆抗體 Polyclonal Antibody to HtrA Serine Peptidase 4 (HTRA4)
kl221Hu01 Dermokine蛋白(DMKN)多克隆抗體 Polyclonal Antibody to Dermokine (DMKN)
kl237Hu01 肝細胞癌相關蛋白1(HCRP1)多克隆抗體 Polyclonal Antibody to Heklocellular Carcinoma Related Protein 1 (HCRP1)
kl251Hu01 Adropin蛋白(AD)多克隆抗體 Polyclonal Antibody to Adropin (AD)
kl280Hu01 食道癌相關基因4(ECRG4)多克隆抗體 Polyclonal Antibody to Esophageal Cancer Related Gene 4 (ECRG4)
kl341Hu01 CD200受體1(CD200R1)多克隆抗體 Polyclonal Antibody to CD200 Receptor 1 (CD200R1)
kl468Hu01 血管生成素樣蛋白6(ANGPTL6)多克隆抗體 Polyclonal Antibody to Angiopoietin Like Protein 6 (ANGPTL6)
kl468Ra01 血管生成素樣蛋白6(ANGPTL6)多克隆抗體 Polyclonal Antibody to Angiopoietin Like Protein 6 (ANGPTL6)
kl557Hu01 補體應答基因32(RGC32)多克隆抗體 Polyclonal Antibody to Response Gene To Complement 32 (RGC32)
kl576Hu01 含Ⅲ型纖連蛋白域蛋白5(FNDC5)多克隆抗體 Polyclonal Antibody to Fibronectin Type III Domain Containing Protein 5 (FNDC5)
kl637Hu01 Pim-3原癌基因(PIM3)多克隆抗體 Polyclonal Antibody to Pim-3 Oncogene (PIM3)
kl690Hu01 含膠原三螺旋重復蛋白1(CTHRC1)多克隆抗體 Polyclonal Antibody to Collagen Triple Helix Repeat Containing Protein 1 (CTHRC1)
kl729Hu01 ⅫB組磷脂酶A2(PLA2G12B)多克隆抗體 Polyclonal Antibody to Phospholikle A2, Group XIIB (PLA2G12B)
kl845Hu01 Epigen蛋白(EPG)多克隆抗體 Polyclonal Antibody to Epigen (EPG)
kl863Mu01 Osterix蛋白(OSX)多克隆抗體 Polyclonal Antibody to Osterix (OSX)
kl894Hu01 含V-Set**球蛋白域蛋白2(VSIG2)多克隆抗體 Polyclonal Antibody to V-Set And Immunoglobulin Domain Containing Protein 2 (VSIG2)
kl942Hu01 自噬相關16樣蛋白1(ATG16L1)多克隆抗體 Polyclonal Antibody to Autophagy Related Protein 16 Like Protein 1 (ATG16L1)
kl122Hu01 無翅型MMTV整合位點家族成員5B(WNT5B)多克隆抗體 Polyclonal Antibody to Wingless Type MMTV Integration Site Family, Member 5B (WNT5B)
kl155Hu01 無翅型MMTV整合位點家族成員3A(WNT3A)多克隆抗體 Polyclonal Antibody to Wingless Type MMTV Integration Site Family, Member 3A (WNT3A)
